Warrant
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ABOS$0.232-3.21%
Acumen Pharmaceuticals, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$16.78M
Float & O/S:
Inst Own:
DilutionScan read 37 of Acumen Pharmaceuticals, Inc.'s SEC filings and found 1 warrant series, 1 convertible, 1 ATM program, 3 shelf registrations and 1 completed offering on file for ABOS. The latest dilution event on file is a registration statement on Oct 28, 2026. Analysis updated Oct 31, 2026.
Signal8 Summary
ABOS
Going-concern warning from auditors
Snapshot
Acumen is a clinical-stage biotech with no revenue and a serious cash problem. The company lost $121.3 million in FY 2025 while burning through $115.6 million in free cash flow.
What's Happening Right Now
- : Acumen presented data at AAIC 2026 showing its EBD candidate ACU401 achieved up to 40-fold greater frontal cortex exposure in non-human primates compared to native antibodies.
- : Acumen nominated two development candidates, ACU301 and ACU401, in its Enhanced Brain Delivery program under a license with JCR Pharmaceuticals.
- : The company reported a narrower Q1 net loss but raised substantial doubt about its ability to continue as a going concern, stating current cash may only fund operations into early 2027.
Raise routes on file: active ATM + effective shelf · latest dilution event 6 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Oct 28, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Outstanding
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
ATM program
Issued 2022
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your ABOS trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
